Report overview
This report aims to provide a comprehensive presentation of the global market for Adoptive Cell Transfer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adoptive Cell Transfer Therapy. This report contains market size and forecasts of Adoptive Cell Transfer Therapy in global, including the following market information:
Global Adoptive Cell Transfer Therapy Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Adoptive Cell Transfer Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
NK Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Adoptive Cell Transfer Therapy include Novartis AG, Kite Pharma, Pfizer, Juno Therapeutics, Celgene Corporation, CARsgen Therapeutics, Sorrento Therapeutics, Legend Biotech and Atara Biotherapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Adoptive Cell Transfer Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Adoptive Cell Transfer Therapy Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Adoptive Cell Transfer Therapy Market Segment Percentages, by Type, 2022 (%)
NK
LAK
DC
CIK
CTL
TIL
TCR-T
CAR-T
Global Adoptive Cell Transfer Therapy Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Adoptive Cell Transfer Therapy Market Segment Percentages, by Application, 2022 (%)
Acute Lymphocytic Leukemia
NHL
Melanoma
Bladder Cancer
Lung Cancer
Head and Neck Cancer
Multiple Myeloma
Other
Global Adoptive Cell Transfer Therapy Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Adoptive Cell Transfer Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Adoptive Cell Transfer Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Adoptive Cell Transfer Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Kite Pharma
Pfizer
Juno Therapeutics
Celgene Corporation
CARsgen Therapeutics
Sorrento Therapeutics
Legend Biotech
Atara Biotherapeutics
Aurora Biopharma
Autolus Therapeutics PLC
Bluebird
Carina Biotech
Athenex
Xiangxue Pharmaceutical (Xiangxue Precision)
Hengrui Yuanzheng
Eureka Therapeutics
WuXi Juno
Shenzhen Inno Immunity
Shenzhen Binde Bio
Kerui Bio
Adaptimmune
Altor Bioscience Corporation
Cellectis
Takara Bio
Unum Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Adoptive Cell Transfer Therapy, market overview.
Chapter 2: Global Adoptive Cell Transfer Therapy market size in revenue.
Chapter 3: Detailed analysis of Adoptive Cell Transfer Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Adoptive Cell Transfer Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
